An Australasian, Multi-centre, Randomized, Double-blind, Placebo-controlled Trial Of The Efficacy Of Fluoxetine In Improving Functional Recovery After Acute Stroke
Funder
National Health and Medical Research Council
Funding Amount
$2,306,367.00
Summary
Stroke is one of the top three causes of disability. Treatments that improve recovery after stroke are lacking. We reviewed the world literature and found a number of very small studies which, together, suggest that the antidepressant drug, fluoxetine, may improve the recovery in stroke patients. AFFINITY is a large trial in 1600 Australians and New Zealanders with stroke which aims to find out whether taking fluoxetine for 6 months after a stroke improves recovery compared to a placebo.
Most strokes are ischaemic due to occlusion of an artery producing rapid reduction in blood flow to the brain. Positioning a patient ‘lying flat’ (i.e. ‘head down’ to be level with the body, which increases the blood flow to the brain, may improve recovery and reduce disability. This study aims to determine whether ‘lying flat’ head positioning is beneficial in patients with acute stroke. The results could lead to a cheaper, safer and more effective stroke care in the world.